{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:41:31Z","timestamp":1790023291194,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T00:00:00Z","timestamp":1485734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.tmaid.2017.01.003","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T23:15:16Z","timestamp":1485818116000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) \u2013 Data of a prospective traveller study"],"prefix":"10.1016","volume":"16","author":[{"given":"Anu","family":"Kantele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sointu","family":"Mero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Kirveskari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinja","family":"L\u00e4\u00e4veri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2017.01.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2017.01.003_bib2","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/jac\/dks214","article-title":"The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae","volume":"67","author":"van der Bij","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2017.01.003_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.47.30074","article-title":"International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review","volume":"20","author":"Hassing","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2017.01.003_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tmaid.2016.11.010","article-title":"Antibiotic resistance and international travel: Causes and consequences","volume":"14","author":"Kuenzli","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw101","article-title":"Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level","author":"Woerther","year":"2017","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.tmaid.2017.01.003_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00365540903493715","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea","volume":"42","author":"Tham","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib7","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00220-10","article-title":"Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers","volume":"54","author":"T\u00e4ngden","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2017.01.003_bib8","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/jac\/dkt167","article-title":"Travel Study Group of Southeast Sweden. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors","volume":"68","author":"\u00d6stholm-Balkhed","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2017.01.003_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1908.130257","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from The Netherlands","volume":"19","author":"Paltansing","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/1471-2334-14-528","article-title":"High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors","volume":"14","author":"Kuenzli","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/ciu957","article-title":"Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"60","author":"Kantele","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2015.04.007","article-title":"Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: a prospective study","volume":"13","author":"Angelin","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics","volume":"61","author":"Ruppe","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"731","key":"10.1016\/j.tmaid.2017.01.003_bib14","article-title":"Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum beta-lactamase-producing Enterobacteriaceae - a prospective cohort study","volume":"22","author":"Reuland","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2017.01.003_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","article-title":"Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study","volume":"17","author":"Arcilla","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2334-10-231","article-title":"Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations","volume":"10","author":"Pitzurra","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2334-11-295","article-title":"Schim van der Loeff MF, Sonder GJ. Incidence, risk factors and treatment of diarrhoea among Dutch travellers: reasons not to routinely prescribe antibiotics","volume":"11","author":"Belderok","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/inf.1983.15.issue-4.07","article-title":"Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea","volume":"15","author":"Stenderup","year":"1983","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJM198201213060302","article-title":"Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim\u2013sulfamethoxazole","volume":"306","author":"Murray","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tmaid.2017.01.003_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib21","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2017.01.003_bib22","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/590062","article-title":"Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy","volume":"47","author":"Paterson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12879-016-1682-0","article-title":"Travelers' health problems and behavior: prospective study with post-travel follow-up","volume":"16","author":"Vilkman","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cmi.2016.02.011","article-title":"Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited","volume":"22","author":"L\u00e4\u00e4veri","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2017.01.003_bib25","series-title":"Clinical breakpoints","author":"European committee on antimicrobial susceptibility testing (EUCAST)","year":"2016"},{"key":"10.1016\/j.tmaid.2017.01.003_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tmaid.2016.11.012","article-title":"International travel is a risk factor for extended-spectrum beta-lactamase-producing Enterobacteriaceae acquisition in children: a case-case-control study in an urban U.S. hospital","volume":"14","author":"Strysko","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/19490976.2015.1019693","article-title":"Characterization of the human gut microbiome during travelers' diarrhea","volume":"6","author":"Youmans","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tmaid.2017.01.003_bib28","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/cid\/civ174","article-title":"As far as travelers' risk of acquiring resistant intestinal microbes is considered, no antibiotics (absorbable or nonabsorbable) are safe","volume":"60","author":"Kantele","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-92-6-770","article-title":"Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial","volume":"92","author":"Stamm","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2017.01.003_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00365548409087147","article-title":"The influence of long-term treatment with mecillinam on fecal Escherichia coli","volume":"16","author":"Moller","year":"1984","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M enzymes: origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tmaid.2017.01.003_bib32","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1128\/AAC.01447-15","article-title":"Genomic and functional portrait of a highly virulent, CTX-M-15-producing H30-Rx subclone of Escherichia coli sequence type 131","volume":"59","author":"Ranjan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"78","key":"10.1016\/j.tmaid.2017.01.003_bib33","first-page":"443","article-title":"Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals","volume":"2014","author":"Sader","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in gram-negative bacilli","volume":"5","author":"Ruppe","year":"2015","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.tmaid.2017.01.003_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmaid.2015.05.005","article-title":"A\u00a0call to restrict prescribing antibiotics for travellers' diarrhea\u2013travel medicine practitioners can play an active role in preventing the spread of antimicrobial resistance","volume":"13","author":"Kantele","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tmaid.2016.06.006","article-title":"Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild\/moderate travellers' diarrhoea","volume":"14","author":"L\u00e4\u00e4veri","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2017.01.003_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3201\/eid2201.151272","article-title":"Increased risk for ESBL-producing bacteria from co-administration of loperamide and antimicrobial drugs for travelers' diarrhea","volume":"22","author":"Kantele","year":"2016","journal-title":"Emerg Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917300030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:28Z","timestamp":1761487348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893917300030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"alternative-id":["S1477893917300030"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.01.003","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) \u2013 Data of a prospective traveller study","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}